TotalMarketCap

Solid Biosciences

SLDBNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$686.405 M

$6.15 -5.67%

Close of 6 Nov 2026

As of 6 Nov 2026, Solid Biosciences (SLDB) has a market capitalization of $686.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

111,610,531

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #51Cullinan TherapeuticsCGEM$704.0M
  2. #52Sana BiotechnologySANA$697.5M
  3. #53Solid BiosciencesSLDB$686.4M
  4. #54Attovia TherapeuticsATTO$684.1M
  5. #55Aura BiosciencesAURA$659.6M

What if Solid Biosciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$252,994.71

Per share 41,137× higher

Bitcoin $1.53T

$13,689.10

Per share 2,226× higher

Apple $5.02T

$44,940.05

Per share 7,307× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Solid Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.